VivoSim Labs VIVS
NASDAQ VIVS
$0.28 0.00 (-0.25%)
As of: Aug 21, 2026 · 1:19 PM EDT

VivoSim Labs (VIVS) Receivables - Net (2014 - 2026)

VivoSim Labs (VIVS) posted quarterly Receivables - Net of $32000.0 for Q1 2026, up 6.67% year-over-year from $30000.0 in Q1 2025, and down 3.03% quarter-over-quarter from $33000.0 in Q4 2025.

VivoSim Labs (VIVS) Receivables - Net (2014 - 2026) Analysis & Trends

VivoSim Labs' Receivables - Net history runs 12 years deep, the most recent figure standing at $32000.0 for Q1 2026.

  • In Q1 2026, Receivables - Net rose 6.67% year-over-year to $32000.0; the TTM figure through Mar 2026 stood at $32000.0 (up 6.67% YoY), while the FY2026 annual figure was $32000.0, up 6.67% from the prior year.
  • Receivables - Net for Q1 2026 stood at $32000.0, down from $33000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $152000.0 in Q1 2023, with the low at $26000.0 in Q4 2024.
  • The 5-year median for Receivables - Net is $33000.0 (2023), against an average of $54285.7.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net plunged 78.29% in 2024, then grew 26.92% in 2025.
  • VivoSim Labs' Receivables - Net stood at $76000.0 in 2022, then tumbled by 56.58% to $33000.0 in 2023, then slipped by 21.21% to $26000.0 in 2024, then rose by 26.92% to $33000.0 in 2025, then fell by 3.03% to $32000.0 in 2026.
  • Business Quant data shows VIVS's Receivables - Net at $32000.0 in Q1 2026, $33000.0 in Q4 2025, and $32000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.35 Bn 131.50 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.12 Bn 78.12 Bn 3.93 Bn
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn
4 Moderna 58.98 Bn 53.84 Bn 52.00 Mn
5 BeOne Medicines 42.08 Bn 36.99 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 27.98 Bn 9.59 Bn 668.28 Mn
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
9 Royalty Pharma 27.30 Bn 26.47 Bn -
10 VivoSim Labs 1.45 Mn 1.45 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 29,000.00
Jun 30, 2026 29,000.00
Mar 31, 2026 32,000.00
Mar 31, 2026 32,000.00
Dec 31, 2025 33,000.00
Dec 31, 2025 33,000.00
Sep 30, 2025 32,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 32,000.00
Jun 30, 2025 32,000.00
Mar 31, 2025 30,000.00
Mar 31, 2025 30,000.00
Dec 31, 2024 26,000.00
Dec 31, 2024 26,000.00
Sep 30, 2024 29,000.00
Sep 30, 2024 29,000.00
Jun 30, 2024 48,000.00
Jun 30, 2024 48,000.00
Mar 31, 2024 33,000.00
Mar 31, 2024 33,000.00